Cirium’s New Aviation Analytics Tools Will Accelerate Digital Transformation and Sustainability in the Aviation Industry
Cirium, the leading aviation analytics company, has committed to supporting the aviation industry accelerate its digital transformation and sustainability goals, with the introduction of a new product suite.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230606005687/en/
CIRIUM’S NEW AVIATION ANALYTICS TOOLS WILL ACCELERATE DIGITAL TRANSFORMATION AND SUSTAINABILITY IN THE AVIATION INDUSTRY (Photo: Business Wire)
The new capabilities that Cirium now offers, include accurate CO₂ emissions forecasting for flights, situational awareness of aircraft, in-depth advance booking analysis, and analytics tools that help assess the value and carbon footprint of an aircraft fleet.
To support this commitment, Cirium has increased its R&D team by 600% to 70 people and will release six new products over the coming months which give access to Cirium’s proprietary mix of data and analytics.
Airlines will be able to run more in-depth operational analyses for strategic decision-making and mitigate upcoming flight disruption. Airports can now analyze global booking and demand data to optimize marketing campaigns and spend. Booking tool providers will be able to provide accurate CO₂ emissions insights in pre-travel information. Aircraft lessors and banks will be able to benchmark aircraft CO₂ emissions to inform sustainability targets.
Jeremy Bowen, CEO of Cirium, said: “Cirium continues to increase its investment in data science and emerging technologies that are creating new, high value analytics. The new products we are bringing to the market in this release, leverage our renowned industry-standard data and deliver increased visibility to the situations faced by the aviation industry every day.
“Cirium is committed to supporting the digitalization of the aviation industry as it rebounds after a turbulent few years, enabling businesses to make critical decisions around airline operations, mitigating disruptions, offering advanced information pre-travel, and making better aircraft investment decisions which meet fuel efficiency targets.”
Under its machine-readable aviation analytics solution Cirium Sky, there will be three new products:
- Cirium Sky Warehouse surfaces a wealth of historical and forward-looking aviation data and analytics for strategic planning and post-operations analysis and is available through either Snowflake or Amazon Redshift cloud software.
- Cirium Sky API – Emissions provides real-time insights around the CO₂ emissions for each scheduled flight in the future, enabling businesses such as booking tool providers to offer carbon-reduction insights for corporate travel.
- Cirium Sky Stream – Positional offers a live stream of aircraft positional data in real-time for situational awareness.
Under Cirium Diio, the industry-leading solution to managing and optimizing network planning and aircraft movement around the world, a new Advanced Bookings tool will allow airports to analyze booking trends and leverage more proactive insights into passenger demand.
Two products will be revealed under Cirium Ascend, which delivers the 360-degree view of aircraft assets, past, present and future:
- Cirium Ascend Risk Analytics enables aircraft financiers to monitor and benchmark the utilization of aircraft assets in their portfolio and inform strategies to reduce CO₂ emissions.
- Cirium Ascend Value Trends provides key value and liquidity metrics by different aircraft asset classes so financiers can improve return on investment and understand aircraft value risk.
Register here to be the first to find out when Cirium’s new products launch.
In addition to Cirium Sky, Diio and Ascend, the company provides traveler analytics tools via its Cirium Journey apps and services which make the traveler journey smooth and informed, and custom analytics via Cirium Blu which meets very specific, customized aviation needs of businesses worldwide.
---ENDS---
Notes to editors:
About Cirium
Cirium brings together powerful data and analytics to keep the world moving. Delivering insight, built from decades of experience in the sector, enabling travel companies, aircraft manufacturers, airports, airlines and financial institutions, among others, to make logical and informed decisions which shape the future of travel, growing revenues and enhancing customer experiences. Cirium is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. The shares of RELX PLC are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RELX.
For further information please follow Cirium updates on LinkedIn or Twitter or visit cirium.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230606005687/en/
Contact information
For media enquiries please contact:
Cirium PR: media@cirium.com
The PC Agency (UK and Europe): cirium@pc.agency
Juliett Alpha Media Relations (Americas): cirium@juliettalpha.com
TrainTracks (Japan): cirium@traintracks.jp
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press Release
Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per
Mori Memorial Foundation’s Global Power City Index 2025 Sees City Rankings Shift Due to Tourism Gains in East Asia and Inflationary Pressures in the West17.12.2025 04:00:00 CET | Press Release
The Mori Memorial Foundation’s Institute for Urban Strategies, a research body established by Mori Building, Tokyo’s leading urban landscape developer, today published its annual Global Power City Index (GPCI) 2025, a report evaluating the urban competitiveness of 48 major cities worldwide. The report also includes the GPCI–Financial Centers index, an assessment of cities as international financial centers, and the new GPCI–Startup Ecosystems index, which assesses the competitiveness of startup environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216187692/en/ 48 Major Cities Evaluated in Mori Memorial Foundation’s GPCI-2025 Report This year’s report highlights the remarkable rise of East Asian cities and the stagnation of several Western cities, showing how global challenges, such as geopolitical tensions and regional disparities in inflation, are greatly impacting the performance of major cities worldwide. The r
GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners17.12.2025 03:00:00 CET | Press Release
GE HealthCare (Nasdaq: GEHC) today announced it will supply more than 300 CT (computed tomography) scanners under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals across all 38 provinces, including urban and remote areas. The CT scanner procurement under SIHREN was conducted through a fully competitive international tender process governed by the World Bank’s procurement regulations. SIHREN is the largest healthcare infrastructure investment in Indonesia’s history and among the largest multilateral health projects globally. SIHREN aims to modernize the national referral system and expand access to diagnostics and treatment across the archipelago, with a focus on non-communicable diseases (NCD) management, maternal health, and pandemic resilience. By mode
IDWS 2025 Concludes with Focus on Global Knowledge Exchange, Financial Opportunities, and Scalable Water Solutions16.12.2025 20:03:00 CET | Press Release
The 4th Innovation Driven Water Sustainability Conference (IDWS) 2025 concluded on Wednesday in Jeddah, confirming its status as one of the world’s most influential platforms for shaping the future of water innovation, sustainability, and security. Gathering senior global policymakers and international industry leaders, this year’s edition has advanced critical dialogue on safeguarding the planet’s most vital resource, with Saudi Arabia at the forefront. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216483490/en/ Investors, innovators, and global institutions gather in Saudi to outline how capital, collaboration, and governance can accelerate long term water sustainability (Photo: AETOSWire) Among the most consequential engagements were a series of meetings that brought together discussions powered by SWA, centred on shared challenges, knowledge exchange, and exploring opportunities within the global water ecosystem. Att
OAG Appoints ex-Skyscanner Executive Filip Filipov as New Chief Executive Officer16.12.2025 17:00:00 CET | Press Release
OAG announces today the appointment of Filip Filipov, ex-Skyscanner executive, as new Chief Executive Officer. Filip Filipov currently serves as the company’s Chief Operating Officer and takes over from Phil Callow who has chosen to step down having completed thirteen transformational years at the helm of OAG to pursue his many other interests. Since joining in 2024, Filipovhas played a leading role in the company’s ambitious next phase of growth and ongoing acceleration. He will now lead OAG into a new era defined by advanced data products and AI-driven intelligence. Before joining OAG, Filipov held senior roles in travel technology and big-data consulting, including on Skyscanner’s executive team. Filip Filipov said: “It’s a privilege to step into this role and lead a company with such a strong heritage and reputation. I’m excited for what’s ahead and committed to serving our customers with the reliability, service, and innovation they depend on.” Chairman of OAG, Gehan Talwatte, com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom